OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Spleen‐targeted neoantigen DNA vaccine for personalized immunotherapy of hepatocellular carcinoma
Ming Wu, Zijin Luo, Zhixiong Cai, et al.
EMBO Molecular Medicine (2023) Vol. 15, Iss. 10
Open Access | Times Cited: 16
Ming Wu, Zijin Luo, Zhixiong Cai, et al.
EMBO Molecular Medicine (2023) Vol. 15, Iss. 10
Open Access | Times Cited: 16
Showing 16 citing articles:
Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives
Ke-Yu Shen, Ying Zhu, Sun‐Zhe Xie, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 47
Ke-Yu Shen, Ying Zhu, Sun‐Zhe Xie, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 47
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
Man Wang, Fei Yu, Yuan Zhang
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 8
Man Wang, Fei Yu, Yuan Zhang
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 8
Cancer vaccines: current status and future directions
Yi Zhou, Yuquan Wei, Xiaohe Tian, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 3
Yi Zhou, Yuquan Wei, Xiaohe Tian, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 3
Spleen-targeted delivery systems and strategies for spleen-related diseases
Ziyao Huang, Kedong Sun, Zhenyu Luo, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 773-797
Closed Access | Times Cited: 14
Ziyao Huang, Kedong Sun, Zhenyu Luo, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 773-797
Closed Access | Times Cited: 14
Red blood cell derived nanocarrier drug delivery system: A promising strategy for tumor therapy
Xin Wang, Kuirong Mao, Xiaonan Zhang, et al.
Deleted Journal (2024) Vol. 2, Iss. 3
Open Access | Times Cited: 10
Xin Wang, Kuirong Mao, Xiaonan Zhang, et al.
Deleted Journal (2024) Vol. 2, Iss. 3
Open Access | Times Cited: 10
Harnessing Immunotherapy for Hepatocellular Carcinoma: Principles and Emerging Promises
Hossein Miri, Payman Rahimzadeh, Mehrdad Hashemi, et al.
Pathology - Research and Practice (2025), pp. 155928-155928
Closed Access | Times Cited: 1
Hossein Miri, Payman Rahimzadeh, Mehrdad Hashemi, et al.
Pathology - Research and Practice (2025), pp. 155928-155928
Closed Access | Times Cited: 1
Spleen-Targeted mRNA Vaccine Doped with Manganese Adjuvant for Robust Anticancer Immunity In Vivo
Zijin Luo, Yi Lin, Yanan Meng, et al.
ACS Nano (2024) Vol. 18, Iss. 44, pp. 30701-30715
Closed Access | Times Cited: 8
Zijin Luo, Yi Lin, Yanan Meng, et al.
ACS Nano (2024) Vol. 18, Iss. 44, pp. 30701-30715
Closed Access | Times Cited: 8
Recent Progress in Cancer Vaccines and Nanovaccines
Kishwor Poudel, Tulasi Vithiananthan, Jong Oh Kim, et al.
Biomaterials (2024) Vol. 314, pp. 122856-122856
Closed Access | Times Cited: 5
Kishwor Poudel, Tulasi Vithiananthan, Jong Oh Kim, et al.
Biomaterials (2024) Vol. 314, pp. 122856-122856
Closed Access | Times Cited: 5
Nanomaterial Delivery Vehicles for the Development of Neoantigen Tumor Vaccines for Personalized Treatment
Xiaoyu Huang, Xiaolong Zhu, Huan Yang, et al.
Molecules (2024) Vol. 29, Iss. 7, pp. 1462-1462
Open Access | Times Cited: 4
Xiaoyu Huang, Xiaolong Zhu, Huan Yang, et al.
Molecules (2024) Vol. 29, Iss. 7, pp. 1462-1462
Open Access | Times Cited: 4
Tailoring Nanovectors for Optimal Neoantigen Vaccine Efficacy
Youshi Zheng, Binghe Wang, Zhixiong Cai, et al.
Journal of Materials Chemistry B (2025)
Closed Access
Youshi Zheng, Binghe Wang, Zhixiong Cai, et al.
Journal of Materials Chemistry B (2025)
Closed Access
Targeting Antigen‐Presenting Cells to Enhance the Tumor‐Spleen Immunity Cycle through Liposome‐Neoantigen Vaccine
Yu Xu, Bing Wang, Yue Huang, et al.
Advanced Science (2025)
Open Access
Yu Xu, Bing Wang, Yue Huang, et al.
Advanced Science (2025)
Open Access
New insights into red blood cells in tumor precision diagnosis and treatment
Gaihua Jia, Jun Wang, Hu Wang, et al.
Nanoscale (2024) Vol. 16, Iss. 25, pp. 11863-11878
Closed Access | Times Cited: 3
Gaihua Jia, Jun Wang, Hu Wang, et al.
Nanoscale (2024) Vol. 16, Iss. 25, pp. 11863-11878
Closed Access | Times Cited: 3
Cell-penetrating peptides TAT and 8R functionalize P22 virus-like particles to enhance tissue distribution and retention in vivo
Shibo Su, Xuegang Shen, Xinqi Shi, et al.
Frontiers in Veterinary Science (2024) Vol. 11
Open Access | Times Cited: 1
Shibo Su, Xuegang Shen, Xinqi Shi, et al.
Frontiers in Veterinary Science (2024) Vol. 11
Open Access | Times Cited: 1
Organ on a chip in nanotechnology
Katarzyna Maria Świst-Szulik
Elsevier eBooks (2024), pp. 215-231
Closed Access
Katarzyna Maria Świst-Szulik
Elsevier eBooks (2024), pp. 215-231
Closed Access
STING Nanoagonist Boosts Antitumor Immunity of Therapeutic DNA Vaccines
Wencong Jia, Janin Chandra, Siok Min Teoh, et al.
Nano Letters (2024)
Closed Access
Wencong Jia, Janin Chandra, Siok Min Teoh, et al.
Nano Letters (2024)
Closed Access
